Litcius/Paper detail

Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

Ángel Arenal, Pablo Ávila, Javier Jiménez‐Candil, Luís Tercedor, David Calvo, Fernando Arribas, Javier Fernández‐Portales, José Luís Merino, Antonio Hernández‐Madrid, F J Fernandez-Aviles, Antonio Berruezo

2022Journal of the American College of Cardiology178 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAmiodaroneCardiologyVentricular tachycardiaInternal medicineCatheter ablationHazard ratioRandomized controlled trialImplantable cardioverter-defibrillatorCardiomyopathyTachycardiaAblationHeart failureAnesthesiaAtrial fibrillationConfidence intervalCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studiesAtrial Fibrillation Management and Outcomes
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia | Litcius